In dogs, immunocytochemistry and immunohistochemistry are commonly applied to discriminate between T-cell (CD3+ and/or CD5+) and B-cell (CD79a+ and/or CD20+) lymphoma [3,4], but are not suitable to detect phenotypic aberrancies. The gene discussed is CD5; the disease is lymphoma.